These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [The risk of cancer induced by omeprazole (Losec) has not increased]. Lund H Tidsskr Nor Laegeforen; 1999 Aug; 119(20):3044. PubMed ID: 10504858 [No Abstract] [Full Text] [Related]
16. Fatal outcome of nevirapine-associated toxic epidermal necrolysis. Leng K; Lonsdorf A; Hartmann M Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560 [TBL] [Abstract][Full Text] [Related]
17. Diffuse alopecia associated with omeprazole. Borum ML; Cannava M Am J Gastroenterol; 1997 Sep; 92(9):1576. PubMed ID: 9317099 [No Abstract] [Full Text] [Related]
19. [Losec was probably the cause of interstitial nephritis]. Jacobson SH; Sundelin B Lakartidningen; 1999 Apr; 96(14):1717-8. PubMed ID: 10222687 [No Abstract] [Full Text] [Related]
20. Delayed-type hypersensitivity reactions due to sodium lauryl sulphate in omeprazole. Sugiura K; Sugiura M; Kawabe Y; Itoh A J Eur Acad Dermatol Venereol; 2009 May; 23(5):610-1. PubMed ID: 19415814 [No Abstract] [Full Text] [Related] [Next] [New Search]